Molecular mechanisms of cell proliferation induced by low power laser irradiation by Gao, Xuejuan & Xing, Da
BioMed  Central
Page 1 of 16
(page number not for citation purposes)
Journal of Biomedical Science
Open Access Review
Molecular mechanisms of cell proliferation induced by low power 
laser irradiation
Xuejuan Gao and Da Xing*
Address: MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, South China Normal University, Guangzhou 510631, PR China
Email: Xuejuan Gao - gaoxj@scnu.edu.cn; Da Xing* - xingda@scnu.edu.cn
* Corresponding author    
Abstract
Low power laser irradiation (LPLI) promotes proliferation of multiple cells, which (especially red
and near infrared light) is mainly through the activation of mitochondrial respiratory chain and the
initiation of cellular signaling. Recently, the signaling proteins involved in LPLI-induced proliferation
merit special attention, some of which are regulated by mitochondrial signaling. Hepatocyte growth
factor receptor (c-Met), a member of tyrosine protein kinase receptors (TPKR), is phosphorylated
during LPLI-induced proliferation, but tumor necrosis factor alpha (TNF-alpha) receptor has not
been affected. Activated TPKR could activate its downstream signaling elements, like Ras/Raf/MEK/
ERK, PI3K/Akt/eIF4E, PI3K/Akt/eNOS and PLC-gamma/PKC pathways. Other two pathways,
ΔΨm/ATP/cAMP/JNK/AP-1 and ROS/Src, are also involved in LPLI-induced proliferation. LPLI-
induced cell cycle progression can be regulated by the activation or elevated expressions of cell
cycle-specific proteins. Furthermore, LPLI induces the synthesis or release of many molecules, like
growth factors, interleukins, inflammatory cytokines and others, which are related to promotive
effects of LPLI.
Background
Cell proliferation is a very important physiological effect
for low power laser irradiation (LPLI) used in clinical
practice. Increased proliferation after LPLI has been
shown in many cell types in vitro, including fibroblasts
from different systems [1-8], keratinocytes [9], human
osteoblasts [10], calvaria osteoblast-like cells [11], lym-
phocytes [12], mesenchymal stem cells (MSCs) and car-
diac stem cells (CSCs) [13], rat Schwann cells [14], aortic
smooth muscle cell (SMC) [15], endothelial cells from
veins [16] and arteries [17,18], quiescent satellite
cells[19,20], human lung adenocarcinoma cells (ASTC-a-
1) [21] and HeLa cells [22]. However, the mechanisms of
cell proliferation induced by LPLI are poorly understood.
Various mechanisms for the mitogenic effects of low
power laser irradiation have been proposed, including lig-
and-free dimerization and activation of specific receptors
that are in the "right energetic state" to accept the laser
energy, leading to their autophosphorylation and down-
stream effects [23], activation of calcium channels result-
ing in increased intracellular calcium concentration and
cell proliferation [24-30]. Red to near infrared light is
thought to be absorbed by mitochondrial respiratory
chain components, resulting in the increase of reactive
oxygen species (ROS), and adenosine triphosphate (ATP)/
or cyclic AMP, and initiating a signaling cascade which
promotes cellular proliferation and cytoprotection
[9,12,23,24,31-37]. Following increased ATP and protein
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synthesis after LPLI, the expressions of growth factors and
cytokines increase and ultimately lead to cell proliferation
[38,39]. Studies have also shown that light irradiation can
alter cellular homeostasis parameters, such as pHi, the
redox state of the cell, and expression of redox-sensitive
factors like NF-κB, which can lead to a proliferation
increase [23,40-42].
Recently, a large number of signaling proteins reported
play an important key role in the process of LPLI-induced
cell proliferation, probably due to the fact that the molec-
ular events they are involved in are the basic response of
the cells to extracellular stimuli. Therefore, we believe that
the investigation of the molecular events induced by LPLI
could eventually reveal the mechanisms of LPLI. This is
the possible reason why more and more researchers are
devoted to this subject. In this paper, we firstly discuss the
discovered mitochondrial photoacceptors and nonmito-
chondrial photoacceptors, respectively; then we review
the studies on the molecular mechanisms of LPLI-induced
proliferation since January 1999, which will serve as a ref-
erence for the researchers in this field.
Review
Photoacceptor for low power laser
Mitochondrial photoacceptors
Photosensitivity might be a common property of higher
animals and could have physiological significance [43].
The light must be absorbed by the endogenous chromo-
phores of cells or tissues for actions. Mitochondria are the
center of many diverse cellular functions integrating sig-
nals between the organelle and the nucleus. It was sug-
gested as early as 1981 that photosensitivity might be a
common mitochondrial property in higher animals [42].
Irradiation of red and near infrared light can lead to the
activation of mitochondrial respiratory chain compo-
nents and the initiation of a signaling cascade which pro-
motes cellular proliferation and cytoprotection [9,23,32].
Photon absorption causes a shift in the molecular config-
uration of the photoacceptor, accompanying with an
associated alteration in the molecular signal of the cell
[44]. The alterations in photoacceptor function are the
primary reactions, and the subsequent alterations in cellu-
lar signaling and cellular functions are secondary reac-
tions [45]. The primary reactions after light absorption are
reviewed previously [23,44]: including singlet-oxygen
hypothesis, redox properties alteration hypothesis, nitric
oxide hypothesis, transient local heating hypothesis and
superoxide anion hypothesis. The secondary reactions
after light absorption are cellular signaling pathways,
mitochondrial retrograde signaling included [42]. The
mitochondrial retrograde signaling is the communication
in cells from mitochondria to the nucleus that influences
many cellular activities under both normal and patho-
physiologic conditions [46,47]. This recently discovered
signaling pathway is opposite to a common and well-
defined pathway transforming information from the
nucleus and cytoplasm to the mitochondria [48]. Mito-
chondrial retrograde signaling is initially defined by the
alteration of mitochondrial membrane potential (ΔΨm)
[46]. Later, other characteristics like changes in the con-
centration of mitochondrial ROS and Ca2+ are introduced.
The modulation of elements of mitochondrial retrograde
signaling (ΔΨm, ROS, Ca2+, NO•, pHi, fission-fusion
homeostasis of mitochondria) by the irradiation are
reviewed recently [42].
There is now a growing body of evidences indicate that
low-intensity red and near-infrared light is acting on cells
through a primary photoacceptor: cytochrome C oxidase,
the terminal enzyme of the mitochondrial electron trans-
port chain [23,43,49-53]. Absorption of light by cyto-
chrome c oxidase can increase ΔΨm, ATP and ROS,
leading to increased energy availability and signal trans-
duction [39,43,54,55]. These biochemical and cellular
changes lead to macroscopic effects, such as increased cell
proliferation or accelerated wound healing [39,51,56].
Cell proliferation of mammalian cells is widely used for
exploring the changes after LPLI. The initial phase of the
cell proliferation, adhesion of cells to a matrix (attach-
ment), as well as DNA and RNA synthesis rate are the cel-
lular responses studied most systematically [42]. Thus,
coincident action spectra [23,43,50] for processes in the
nucleus (DNA and RNA synthesis) and the plasma mem-
brane (attachment) with the absorption spectra of poten-
tial photoacceptors, together other evidences [32,49,55]
prove that cytochrome c oxidase is a primary photoaccep-
tor of light in the red to near infrared region.
Cytochrome c oxidase of mammalian cells is a large mul-
ticomponent membrane protein (molecular size 200
kDa). Its possible absorbing chromophores for visible
light are two heme moieties (heme a and heme a3), two
redox-active copper sites (CuA, and CuB,), one zinc, and
one magnesium [23]. It has been showed that fully oxi-
dized or fully reduced cytochrome c oxidase cannot be
considered as a primary photoacceptor but only when it is
in one of the intermediate forms (partially reduced or
mixed-valence enzyme) [23]. Under normal physiological
conditions, fully oxidized or fully reduced cytochrome c
oxidase is not present, but only more reduced or less
reduced (less oxidized or more oxidized) forms [50]. In
the process of respiration, the CuA chromophore of cyto-
chrome c oxidase (more exactly, a pair of CuA chromo-
phores) accepts electrons from the cytochrome c
molecule; internal electron transfer among CuA, heme a,
and the heme a3-CuB center results in reduction of molec-
ular oxygen via at least seven redox intermediates [57].
Thus, it is unclear which one of the cytochromes c oxidase
intermediates is the primary photoacceptor.Journal of Biomedical Science 2009, 16:4 http://www.jbiomedsci.com/content/16/1/4
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Other study shows that low-level laser therapy (AsGa,
wavelength of 904 nm) of animals significantly increases
the activities of complexes II and IV of mitochondrial res-
piratory chain components but does not affect succinate
dehydrogenase (SDH, a part of complex II) activity [58].
In contrast to red and near-infrared light, in the blue spec-
tral region, flavoproteins such as NADH-dehydrogenase, a
part of complex I of mitochondrial respiratory chain com-
ponents, can work as photoacceptors [59].
The prosthetic group of heme in cytochromes b, c1 and c
is iron protoporphyrin IX (PpIX), the same heme as in
myoglobin and hemoglobin [60], which has been
reported to have high absorption of green light. Absorp-
tion of laser light energy by PpIX causes photobleaching
due to its photodynamic action. In recent study, after low
power green laser (532 nm, 30 mW) irradiation, ΔΨm of
B-14 cells is significantly increased (by 13%). Fluores-
cence emission spectra analysis shows that fluorescence
maximum at 635 nm, corresponding to emission of PpIX,
is significantly lower in irradiated mitochondria suspen-
sions, suggesting that PpIX is photobleached by low
power green laser irradiation [61]. Thus, it is possible that
PpIX of cytochromes b, c1 and c absorbs the green light.
Nonmitochondrial photoacceptors
Enhancement of cellular metabolism via activation of
nonmitochondrial photoacceptors has been reviewed in
detail elsewhere [44]. Briefly, in phagocytic cells irradia-
tion initiates a nonmitochondrial respiratory burst (pro-
duction of ROS, especially superoxide anion) through
activation of NADPH-oxidase located in the plasma mem-
brane [44]. Another important redox chains are NO-syn-
thases, a group of redox-active P450-like
flavocytochromes that are responsible for generation of
NO under physiological conditions [62]. But, the irradia-
tion effects on these systems have not been investigated
well.
Recent study shows that in cardiac and sperm cells after
the halogen lamp irradiation, only the 400–500 nm range
of visible light can produce oxyradicals. The endogenous
photosensitizer is found predominantly in the cytoplasm
and is smaller than 12 kD [63]. Flavins, a small and water
soluble photosensitizer active only at wavelengths shorter
than 500 nm, have previously been found to be responsi-
ble for visible light induction of free radical reactions in
cell medium [64]. The researchers suggest that flavins are
responsible for the photosensitization of the observed
oxyradicals in cells [63]. Flavin is present in cells primarily
as flavin adenine dinucleotide (FAD) and flavin mononu-
cleotide (FMN). Most flavin molecules in the cell are
bound to proteins, and this may reduce their reactivity
[63].
The photobiological action is mainly through the activa-
tion of the respiratory chain of mitochondria, thus, we
focus mainly on the components of mitochondrial respi-
ratory chain. Reported primary photoacceptors include
cytochromes c oxidase (red and near-infrared light
region), NADH-dehydrogenase (blue spectral region),
and cytochromes b, c1 and c (green light region). Their
cofactors are porphyrins (for cytochromes c oxidase and
cytochromes b, c1 and c), or flavins (for NADH-dehydro-
genase), respectively. Thus, it is possible that photoab-
sorbing molecules in the cell like porphyrins and
flavoproteins (some respiratory-chain components
belong to these classes of compounds) can be reversibly
converted to photosensitizers [65].
How are the primary reactions of photons with photoac-
ceptors in the respiratory chain connected with DNA and
RNA synthesis in the nucleus or with changes in the
plasma membrane? The principal answer is that between
these events are secondary reactions (cellular signaling
cascades or photosignal transduction and amplification
chain) [44]. The elements of mitochondrial retrograde sig-
naling (ΔΨm, ROS, Ca2+, NO￿, pHi, fission-fusion home-
ostasis of mitochondria) are involved in these secondary
cellular signaling cascades. The changes of these elements
of mitochondrial retrograde signaling mediate the activa-
tion or suppression of signal molecules in the cytoplasm
and subsequent changes of downstream cascades, leading
to the synthesis of DNA, RNA, proteins and enzymes in
the nucleus and cytoplasm or the changes in the plasma
membrane. Finally, these changes result in the photobio-
logical effects of cells like proliferation and differentia-
tion.
Signal transduction pathways involved in LPLI-induced cell 
proliferation
Now, we mainly review the involvements of signal mole-
cules in secondary cellular signaling in respond to light
irradiation. Some of these reported signal molecules are
related to the changes of elements of mitochondrial retro-
grade signaling. Whether other reported signal molecules
are related to the changes of elements of mitochondrial
retrograde signaling need to be investigated further.
TPKR/Ras/Raf/MEK/ERK/Mnk1/eIF4E/CyclinD1 pathway
In mammalian cells, there are at least three distinct MAPK
cascades that are activated by different extracellular stim-
uli. The extracellular signal-regulated protein kinase
(ERK) pathway appears to play an important role in
growth-factor-induced proliferation, differentiation and
cellular transformation [66]. Upon epidermal growth fac-
tor (EGF) stimulation, the sequential activation of small
GTPase Ras protein, the Raf-1, the MAPK kinase (MEK1/
2) and two ERK isoforms (ERK1/2) are involved [66]. Two
other MAPK cascades are the stress-activated proteinJournal of Biomedical Science 2009, 16:4 http://www.jbiomedsci.com/content/16/1/4
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kinases (SAPKs)/Jun N-terminal kinases (JNKs) and p38
MAPK, which can be activated by stress signals like heat
shock, UV irradiation, high osmolarity and proinflamma-
tory cytokines (tumor necrosis factor α, TNF-α) [67,68]. It
has been reported that LPLI (He-Ne laser, 632.8 nm)
could induce the phosphorylation of tyrosine protein
kinase receptor (TPKR) (such as c-Met, receptor of hepato-
cyte growth factor), previously shown to activate the
MAPK/ERK pathway, and promote proliferation of the
cells [69]. However, LPLI has no effects on TNF-α receptor
which activates the p38 and JNK pathways [69]. Subse-
quently, by phospho-specific antibodies, the activation of
MAPK/ERK, but not JNK and p38 MAPK kinases, are
detected after LPLI stimulation [69]. Thus, through spe-
cific receptor phosphorylation, LPLI does not work via a
stress signal pathway but rather a mitogen-activated path-
way that leads to the activation and proliferation of quies-
cent satellite cells (Fig. 1).
Eukaryotic initiation factor 4E (eIF4E) is a major regulator
of cap-dependent mRNA translation in response to prolif-
erative stimuli like hormones, growth factors and
mitogens [70,71]. The regulation of eIF4E protein are
mainly through three mechanisms: (a) regulation of eIF4E
expression [72]; (b) phosphorylation of eIF4E [73]; and
(c) phosphorylation-dependent dissociation of the trans-
lational-repressor protein from eIF4E (PHAS-I: protein
heat and acid stable, also as eIF4E binding protein-1
4EBP1) [74,75]. The non- or partial phosphorylation
form of PHAS-I inhibit the activity of eIF4E by strongly
interacting with eIF4E. LPLI stimulation increases the
phosphorylation of eIF4E, but doesn't affect the expres-
sion level of eIF4E [76]. Also, LPLI elevates the phosphor-
ylation of its inhibitory binding protein PHAS-I, as well as
the expression of cyclin D1. These results suggest that the
mechanisms (b) and (c) are involved in the activation of
eIF4E induced by LPLI and that protein translation is ini-
tiated during the process of LPLI treatment [76]. However,
in the presence of the MEK inhibitor, PD98059, LPLI-
induced ERK1/2 activation and eIF4E phosphorylation
are abolished and expression of cyclin D1 is dramatically
reduced [69,76] (Fig. 1).
Although eIF4E phosphorylation is through Ras/Raf/ERK
pathway, but eIF4E is not directly activated by MAPK/
ERK. The eIF4E can be directly phosphorylated by
mitogen-activated protein kinase-interacting kinase 1 and
2 (Mnk1 and Mnk2), and the latter are phosphorylated by
p38 MAPK or MAPK/ERK [77-79]. The authors proposed
that Mnk1 is responsible for the phosphorylation of eIF4E
[76] (Fig. 1). Thus, LPLI initiates protein translation and
induces cell proliferation via the TPKR/Ras/Raf/MEK/
ERK/Mnk1/eIF4E/Cyclin D1 pathway.
TPKR/PI3K/Akt/mTOR/eIF4E pathway
Phosphoinositide 3-kinases (PI3Ks) are important down-
stream kinases of transmembrane TPKR. The involvement
of PI3K in the LPLI-induced cell proliferation is proved by
employing the inhibitor of PI3K, wortmannin [76]. Akt
phosphorylation is enhanced upon LPLI (He-Ne laser,
632.8 nm) stimulation and is attenuated in the presence
of wortmannin [76]. The mammalian target of rapamycin
(mTOR), a downstream kinase in the PI3K pathway, is
thought to phosphorylate PHAS-I [80]. The authors pro-
pose that the activated Akt directly phosphorylates mTOR,
which in turn induces PHAS-I phosphorylation
[76,81,82]. The phosphorylated PHAS-I dissociates from
eIF4E, allowing eIF4E to form the initiation complex and
trigger translation [75,83,84]. After preincubation with
the PI3K inhibitor, wortmannin, LPLI-induced phosphor-
ylation of eIF4E and PHAS-I is abolished and LPLI-
induced expression of cyclin D1 is reduced [76] (Fig. 1).
Thus, these reports suggest that LPLI initiates protein
translation and induces cell proliferation partly via the
TPKR/PI3K/Akt/mTOR/eIF4E pathway.
PI3K/Akt/eNOS pathway
Nitric oxide (NO) has been shown to promote angiogen-
esis and vasculogenesis, which are the indispensable proc-
esses for tissue growth [85,86]. Endothelial NO synthase
(eNOS) produces NO constitutively at low levels, which
can be transiently stimulated to produce high levels of NO
by hormones or various extracellular stimuli [87,88]. The
proliferation and migration of endothelial cell play criti-
cal roles in angiogenesis [89]. Many growth factors, via
PI3K/Akt/eNOS signaling pathway, have been reported to
modulate endothelial cell proliferation, migration and
angiogenesis [90-92]. He-Ne laser irradiation at 632.5 nm
has been reported to increase human umbilical vein
endothelial cell (HUVEC) proliferation, migration, NO
secretion and promote angiogenesis [93]. During this
process of LPLI stimulation, LPLI increases eNOS protein
expression and gene expression (less than 0.26 J/cm2) in
endothelial cells. The increased eNOS expression is inhib-
ited by PI3K inhibitor LY294002, indicating that the acti-
vation of PI3K/Akt pathway is a critical step for the
increased expression of eNOS upon LPLI [93] (Fig. 1).
Thus, these findings suggest that PI3K/Akt/eNOS pathway
is involved in the endothelial cell proliferation induced by
low power He-Ne laser irradiation.
TPKR/PLC-gamma/PKC pathway
Activated TPKR also can activate the catalytic activity of
phospholipase C (PLC)-gamma [28,94]. The activated
PLC could catalyze the hydrolysis of some phospholipids,
and then increase the concentration of diacylglycerol
(DAG) and inositol triphosphate (IP3) in the cytoplasm.
IP3 causes the endoplasmic reticulum (ER) to release Ca2+
which works with DAG to activate PKCs [95-97]. By using
the specific inhibitors, TPK/PLC/PKC/NADPH oxidase
signal transduction pathways has been suggested to par-
ticipate in the He-Ne laser-induced respiratory burst of
neutrophils [28].Journal of Biomedical Science 2009, 16:4 http://www.jbiomedsci.com/content/16/1/4
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PKCs are involved in different functions, including the
cellular proliferation, tumor promotion, differentiation,
and apoptosis of many types of cells [95,98]. PKC was first
described as a Ca2+ activated, phospholipid-dependent
serine/threonine protein kinase [99,100]. The 13 mem-
bers of the PKC family can be divided into three sub-
families, based on their second messenger requirements:
conventional (or classical) PKCs, requiring Ca2+ and DAG
for activation; novel PKCs, requiring DAG, but not requir-
ing Ca2+ for activation; and atypical PKCs, requiring nei-
ther Ca2+  nor DAG for activation [101,102]. In our
previous study, we investigated the involvement of PKCs
Signal pathways involved in LPLI-induced cell proliferation Figure 1
Signal pathways involved in LPLI-induced cell proliferation. Solid shapes mean the involvements of these molecules 
have been reported; Hollow shapes mean the involvements of these molecules have not been reported. Broken lines mean 
that the downstream changes didn't produce by the upstream directly.Journal of Biomedical Science 2009, 16:4 http://www.jbiomedsci.com/content/16/1/4
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in LPLI (He-Ne laser, 632.8 nm)-induced human lung
adenocarcinoma cells (ASTC-a-1) proliferation [21]. By
using laser scanning confocal microscope and fluores-
cence resonance energy transfer (FRET) technique, we
showed the increased activation of PKCs in living cells
during LPLI-induced proliferation. The increases of Ca2+
concentration [24,28-30] and DAG in the cytoplasm have
also been observed in the process of respiratory burst of
neutrophils induced by LPLI [28]. Thus, we suppose that
the Ca2+- and DAG-dependent classical PKCs may be
involved in this process and that LPLI-induced cell prolif-
eration is partly via the TPKR/PLC-gamma/PKC pathway
(Fig. 1).
ΔΨm/ATP/cAMP/JNK/AP-1 pathway
Recent study demonstrated that He-Ne laser (632.8 nm)
irradiation induces an immediate increase in mitochon-
drial membrane potential (ΔΨm), ATP, and cAMP of
melanoma cell line A2058 cell via enhanced cytochrome
c oxidase activity [39]. The ΔΨm is a sensitive indicator for
the energetic state of the mitochondria and therefore the
whole cells [103]. Later, LPLI promotes phosphorylation
of Jun N-terminal kinase (JNK) and results in an activa-
tion of the transcription factor activator protein-1 (AP-1).
The cell proliferation induced by LPLI is significantly
abolished by the addition of chemicals that decreases
ΔΨm or inhibits JNK. These results are not consistent with
the above mentioned result that the activation of MAPK/
ERK, but not JNK and p38 MAPK kinases, is involved in
the proliferation of quiescent satellite cells upon LPLI
[69]. It is probably that these two cells initiate different
signaling pathways during proliferation induced by LPLI.
JNK is activated by growth factor stimulation and is phos-
phorylated primarily in response to cellular stress [104].
AP-1, an downstream kinase of JNK, promotes expression
of genes involved in cell survival, proliferation, and ang-
iogenesis [105]. cAMP, an important intracellular messen-
ger, is capable of regulating differentiation, proliferation,
and synaptic plasticity. Light irradiation causes cAMP ele-
vation, which in turn stimulates both DNA and RNA syn-
thesis [106]. cAMP analog significantly enhances the
phosphorylation of JNK [39]. cAMP elevating agents can
induce transcription factor AP-1 activity [107].
Taken together, these findings suggest that the signaling
pathway cytochrome c oxidase/ΔΨm/ATP/cAMP/JNK/AP-
1 is involved in the regulation of melanoma cell prolifer-
ation induced by LPLI. This investigation binds together
light action upon the photoacceptor (putatively cyto-
chrome c oxidase), modulation of elements of mitochon-
drial retrograde signaling (ΔΨm) and cell proliferation via
AP-1[39].
ROS/Src pathway
LPLI could induce the production of reactive oxygen spe-
cies (ROS) [9,12,22,24,34-37], which functions as the key
secondary messengers regulating the activity of various
protein kinases [40,108]. Non-receptor tyrosine kinases,
particularly the Src kinases, are well-known targets of ROS
and can be activated by oxidative events [109]. Beside the
well known C-terminal tyrosine dephosphorylation acti-
vation system, Src is proposed to possess redox switch. It
has been recently reported that Src is directly oxidized by
the burst ROS during integrin-mediated cell adhesion and
that this oxidation, which involves two sulfhydryl groups,
namely, Cys245 in the SH2 domain and Cys487 in the
kinase domain, leads to the enhanced activation of c-Src
[110].
Src family kinases play key roles in regulating the funda-
mental cellular processes, including cell proliferation,
attachment, migration and survival [111]. In our recent
study, we investigated the involvement of Src in LPLI (He-
Ne laser, 632.8 nm)-induced biostimulatory effects [22].
We firstly showed that LPLI increased the intracellular
ROS level. Using a Src reporter based on fluorescence res-
onance energy transfer (FRET) technique and confocal
laser scanning microscope, we visualized the dynamic Src
activation in HeLa cells immediately after LPLI. Moreover,
Src activation by LPLI was in a dose-dependent manner. In
the presence of vitamin C, catalase alone, or the combina-
tion of catalase and superoxide dismutase (SOD), the acti-
vation of Src by LPLI was significantly abolished. Our
results demonstrated that it was ROS that mediated Src
activation by LPLI and that LPLI-induced change of cell
viability is partly via the ROS/Src pathway. Taken
together, our findings show the connection between the
element of mitochondrial retrograde signaling (ROS) and
secondary cellular reactions of Src activation, finally lead-
ing to the changes of HeLa cell viability.
The involvement of Bcl-2, BAX, p53 and p21 in LPLI-induced survival
The BCL-2 family members are major regulators of the
apoptotic process. This family is comprised of pro-apop-
totic (e.g. BAX) and anti-apoptotic (e.g. Bcl-2, Bcl-Xl) mol-
ecules [112]. Activated p53 mediates growth arrest and
apoptosis by activating the expression of a number of cel-
lular genes like p21 and BAX [113,114]. Under serum-
deprivation conditions normally leading to apoptosis,
LPLI (He-Ne laser, 632.8 nm) stimulation has been
shown to promote the survival of fibers and their adjacent
satellite cells, as well as cultured myogenic cells [20].
Upon LPLI stimulation, the expression of the anti-apop-
totic protein Bcl-2 is markedly increased, whereas expres-
sion of the proapoptotic protein BAX is reduced. In the
meanwhile, the expressions of p53 and the cyclin-depend-
ent kinase inhibitor p21 are reduced [20]. The protectiveJournal of Biomedical Science 2009, 16:4 http://www.jbiomedsci.com/content/16/1/4
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effect of elevating Bcl-2 expression in response to LPLI
could be mediated by the suppression of p53 expression
[114], or LPLI directly induces expression of Bcl-2 at the
posttranscriptional level [20]. These findings imply that
the protective effects of LPLI against apoptosis and pro-
moting survival are partly mediated by regulation of these
factors.
Cell cycle-specific proteins involved in cell cycle 
progression induced by LPLI
The cell cycle is a crucial event in cell biology that consists
of a series of repeated events allowing the cell to grow and
duplicate correctly. Normal eukaryotic cell cycle consists
of the following four discrete phases (Fig. 2): G1 (the time
after cytokinesis and before the S phase), S (DNA synthe-
sis), G2 (the time between S and M phase), and M (cell
mitosis) [115,116]. By summarizing a large number of
experiments the researchers proposed that the G1 phase of
the mammalian cell could be subdivided into two phases,
the early G1 phase and the later G1 phase. Cells in the
early G1 phase could enter the G0 phase, and those in the
later G1 phase could not [117]. G0 phase is the dormancy
phase when the cell is not really doing anything at all. The
point of discrimination is associated with the restriction
point of cell cycle [118]. The normal progression of four
phases of cell cycle is very important for normal cell
growth.
c-fos
The c-fos proto-oncogene can be differentially regulated by
various mitogenic agents at the transcriptional level dur-
ing cell-cycle progression, differentiation, and develop-
ment [119-121]. Ca2+ can modulate the expression of a
number of early response eukaryotic genes in isolated
cells, however, c-fos gene expression merits special atten-
tion [120-122]. In recent study, He-Ne laser (632.8 nm)
irradiation causes the increase of ΔΨm in isolated hepato-
cytes and the uptake of Ca2+ by mitochondria, the latter
could account for stimulation of energy metabolism
[123]. Later, light irradiation triggers the activation of
Ca2+-dependent c-fos gene and elevates the expression of
c-fos in isolated hepatocytes [123]. These results show the
connection between the elements of mitochondrial retro-
grade signaling (ΔΨm and Ca2+) and secondary cellular
reactions of c-fos gene expression in response to LPLI. It
has been reported that the expression of c-fos gives rise to
a G0/G1 transition of the cell cycle in isolated hepatocytes
[124]. Thus, it is possible that the elevated expression of c-
fos induced by LPLI promotes the quiescent cell leave G0
phase and enter G1 phase (Fig. 2).
Cyclin D1, cyclin E, cyclin A and PCNA
Cyclin D1 is a critical target for proliferative signals and
required for cell-cycle progression in G1 phase [125]. Cyc-
lin E is induced at the G1/S boundary, and cyclin A is
induced at a later phase of the cell cycle and is required for
the cell to progress through the S phase [126]. Three sec-
onds of He-Ne laser (632.8 nm) irradiation increases the
expressions of cell-cycle regulatory proteins: cyclin D1,
cyclin E and cyclin A in mouse satellite cells, pmi28. The
induction of cyclin D1 expression is detected as early as 6
minutes after irradiation, suggesting that LPLI increases
the protein synthesis and that LPLI initiates the transla-
tion of proteins that are required for entrance and progres-
sion through the G1 phase of the cell cycle [76]. It has
been reported that sustained activation of ERK1 is
required for the continued expression of cyclin D1 in the
G1 phase [127,128] and that the sustained activation of
ERK1 is detected during LPLI-induced cell proliferation
[69]. LPLI stimulation also upregulates the expression of
another early cell-cycle protein, proliferating cell nuclear
antigen (PCNA), in the late G1 phase in primary rat satel-
lite cells [19]. These findings imply that laser irradiation
allows the cells to pass through G1 phase and enter S
phase by affecting early cell-cycle regulatory genes, and
that cell proliferation increases at last (Fig. 2).
PML
Checkpoint regulator proteins control entrance of the cell
cycle from a quiescent state, as well as progression in the
cell cycle. One such protein, the promyelocytic leukemia
protein (PML), blocks the entry of the cells to S phase of
the cell cycle [129]. PML protein is typically concentrated
in subnuclear PML oncogenic domains (PODs) [20],
together with other important cell cycle regulatory pro-
teins like p53. The localization and distribution of PML in
the cells are related to the cell cycle progression [21]. The
redistribution of PML from PODs to the nucleoplasm is
considered to be the evidence that the cell is leaving the
quiescent stage and entering the S phase[31].
Upon LPLI of human keratinocytes with light at 780 nm,
the ΔΨm is increased immediately and the subnuclear dis-
tribution of PML is altered from discrete domains to its
dispersed form within less than 1 hour. By 3 hours after
irradiation, the intensity of PML fluorescence is markedly
reduced compared with control cells, suggesting that the
PML protein is largely degraded [31]. The ΔΨm is a sensi-
tive indicator for the energetic state of the mitochondria
and therefore the whole cells [103]. These results show the
connection between the element of mitochondrial retro-
grade signaling (ΔΨm) and secondary cellular reactions of
the alteration of PML distribution in response to LPLI.
Thus, LPLI may induce cell cycle progression from G1 to
the S phase through redistribution and degradation of
PML protein, thereby enabling cell proliferation [31] (Fig.
2).Journal of Biomedical Science 2009, 16:4 http://www.jbiomedsci.com/content/16/1/4
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MCM3
Minichromosome maintenance deficient 3 (MCM3) as
licensing factor is involved in the initiation of DNA repli-
cation in eukaryotic cells. Upon LPLI (gallium-aluminum-
arsenide (Ga-Al-As) diode laser), mRNA levels of MCM3
are elevated in laser-irradiated osteoblast cells compared
with the levels in control cells. Furthermore, radiolabelled
thymidine incorporation is increased under laser-irradia-
tion conditions. These findings imply that LPLI enhances
DNA replication mediated by the enhancement of the
MCM3 gene expression and plays an important role in
proliferation of osteoblast [130] (Fig. 2).
14-3-3-sigma and phospho-p53
LPLI (gallium-aluminum-arsenide (Ga-Al-As) diode
laser) induces differentiation of osteoblastic cells by the
increases of Runx2 expression and ALP-positive colonies.
By 12 hours after irradiation, a higher proportion of cells
Cell cycle-specific proteins involved in cell cycle progression induced by LPLI Figure 2
Cell cycle-specific proteins involved in cell cycle progression induced by LPLI.Journal of Biomedical Science 2009, 16:4 http://www.jbiomedsci.com/content/16/1/4
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are in the G2/M boundary of the cell cycle compared with
the control. This result is confirmed by the appearance of
G2/M arrest marker 14-3-3-sigma or phospho-p53. These
findings demonstrate that LPLI induces not only accelera-
tion of bone formation but also initiation of G2/M arrest,
which may promote wound healing [131] (Fig. 2).
Signal molecules involved in inflammatory response 
reduced by LPLI and immunomodulatory effects enhanced 
by LPLI in animal modes
Signal molecules involved in inflammatory response reduced by LPLI 
in animal modes
Transcription factor nuclear factor kappa B (NF-κB)
belongs to the Rel family of DNA-binding proteins and is
present in the cytoplasm in an inactive state as a dimer
bound with the inhibitory IκB protein [132]. A variety of
external stimuli, such as ROS, proinflammatory cytokines,
or phorbol esters, can activate NF-κB via phosphorylation
of IκB by IκB kinases (IKK) [132]. Activated NF-κB can
enhance the expression of different genes, and is essential
for the activation of inducible form of nitric oxide syn-
thase (iNOS) expression in rat gastrocnemius muscle and
skeletal muscle myocites [133-135].
During the inflammatory phase of trauma, factors like
phagocytic stimuli increase the production of reactive oxy-
gen species (ROS), resulting in oxidative stress [136,137].
It has reported that ROS may directly damage vital cell
constituents, such as lipids, proteins, and DNA [138], and
that ROS also can activate NF-κB that is accompanied with
increased degradation of its inhibitor IκB. The activated
NF-κB, in turn, increases the expression of the iNOS and
subsequent synthesis of NO [133,135]. NO and its reac-
tive nitrogen intermediates may destruct cells and tissues
and play a significant role in the pathology of many
inflammatory conditions [139].
In an animal mode, upon LPLI (galium arsenide (Ga-As)
laser, 904 nm), the release of ROS induced by trauma is
blocked and the activation of NF-κB induced by trauma is
also blocked. In the meanwhile, the reduction of the
trauma-induced IκB protein is significantly inhibited. Fur-
thermore, LPLI also reduces the associated overexpression
of iNOS and production of collagen. These findings sug-
gest that LPLI reduces the inflammatory response induced
by trauma in the gastrocnemius muscle of rat [140].
In the lung neutrophils obtained from mice subjected to
lipopolysaccharide (LPS)-induced lung inflammation, the
mRNA levels of anti-apoptotic Bcl-xL and A1 mRNA are
increased. When the mice are treated with LPLI (660 nm
diode laser) and an inhibitor of NF-κB nuclear transloca-
tion (BMS 205820), the mRNA levels of Bcl-xL and A1
mRNA are decreased in lung neutrophils. Thus, LPLI
reduces the levels of anti-apoptotic factors by an action
mechanism in which NF-κB seems to be involved [141].
These findings indicate that LPLI reduces the inflamma-
tory response induced by LPS in LPS inflamed mice lung
neutrophils. The decreased mRNA level of anti-apoptotic
protein Bcl-xL after LPLI in this animal mode is not con-
sistent with the result that LPLI increases the expression of
anti-apoptotic protein Bcl-2 in cultured cells [20]. Thus, it
is impossible that LPLI-reduced inflammatory response
and LPLI-induced cell survival are through the exact same
mechanisms. We suppose that the human (or animal)
body not single cell keeps the balance between normal
developments induced by promotive elements and abnor-
mal developments induced by pathological elements. The
abnormality predominates in the body developments
under pathological conditions. LPLI stimulation serves as
a very advantageous regulating element by inhibiting the
abnormal developments and strengthening immunity
against pathological conditions.
Signal molecules involved in immunomodulatory effectsenhanced by 
LPLI in animal modes
The increased immunomodulatory effect is observed in
the following animal model. Using periodic He-Ne laser
radiation on the thymus zone of animal for 1 month, the
authors detect more pronounced changes in the cytokine
production as well as in NO and Hsp70 synthesis. Thus,
LPLI shows more effective immunomodulatory effects
when applied on the thymus projection area of animal
[142].
Expression and secretion of molecules induced by LPLI
Expression and secretion of growth factors induced by LPLI
It has been shown that LPLI significantly increases the
gene or protein expressions of several growth factors
(Table 1), including brain derived neurotrophic factor
(BDNF) and glial derived neurotrophic factor (GDNF) in
olfactory ensheathing cells [143], bFGF growth factor pro-
duction in fibroblasts [144], insulin-like growth factor
(IGF)-I in the calvarial cells [145], keratinocyte growth
factor (KGF) in human keratinocytes [31], platelet-
derived growth factor (PDGF) in cultured fibrob-
lasts[146], transforming growth factor-β (TGF-β) in the
cardiomyocytes [18,147], transforming growth factor-β1
(TGF-β1) [39,148,149], vascular endothelial growth fac-
tors (VEGF) by smooth muscle cells, fibroblasts, cardio-
myocytes and cardiac myocytes [18,147,150]. Among
these growth factors, before up-regulation of KGF in kerat-
inocytes [31] and release of TGF-β1 from melanoma cells
[39], the researchers examine the immediate increase in
ΔΨm level after light irradiation, which suggests the con-
nection between the elements of mitochondrial retro-
grade signaling and secondary cellular reactions of
expression and secretion of growth factors. Accompanied
with increased expressions of these growth factors, the
cells exhibit the corresponding biological effects inducedJournal of Biomedical Science 2009, 16:4 http://www.jbiomedsci.com/content/16/1/4
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by LPLI, such as cell proliferation, differentiation and
bone nodule formation.
Expression and secretion of interleukins induced by LPLI
Following irradiation of human keratinocytes with light at
780 nm, the ΔΨm is increased immediately and then the
expression of interleukin-1alpha (IL-1α) and interleukin-
6 (IL-6) are transiently unregulated (Table 1) [31]. He-Ne
irradiation of melanoma cell line A2058 cells induces an
immediate increase in ΔΨm, ATP, and cAMP via enhanced
cytochrome c oxidase activity and results in delayed effects
on interleukin-8 (IL-8) release [39]. IL-1α, IL-6 and IL-8
could provoke proliferation of keratinocytes and
melanoma cells, respectively; moreover, IL-1α also could
induce keratinocytes migration. It is possible that these
cytokines play a critical role in the enhancement of kerat-
inocyte and melanoma cells proliferation and migration
of keratinocyte induced by LPLI. These results show the
connection among photoacceptor (cytochrome c oxi-
dase), element of mitochondrial retrograde signaling
(ΔΨm), secondary cellular responses of expression and
secretion of IL-1α, IL-6 and IL-8, and cells proliferation
and migration. In addition, the levels of IL-2 mRNA and
IL-4 mRNA after irradiation of skin are increased, which
suggests that LPLI affects the cutaneous immunological
activation [151].
Expression and secretion of inflammatory cytokines induced by LPLI
After LPLI, the decreased expressions of several inflamma-
tory cytokines are observed (Table 1). Lipopolysaccharide
(LPS) is known as a potent stimulator of inflammation
[152]. In human gingival fibroblast (hGF) cells, LPLI (Ga-
Al-As diode laser) significantly inhibits production of
prostaglandin E2 (PGE2) and decreases the mRNA levels
of cyclooxygenase-2 (COX-2) induced by LPS [152]. In
human keratinocytes and porcine aortic SMC, after irradi-
ation, the expression of the proinflammatory gene inter-
leukin-1beta (IL-1β) is suppressed, this finding reflects the
suppression of inflammation by LPLI [15,31]. Before the
suppression of IL-1β expression in keratinocytes, the
increase of ΔΨm is monitored immediately after LPLI,
which suggests the connection between element of mito-
chondrial retrograde signaling (ΔΨm) and secondary cel-
lular responses. In Wistar rats, LPLI (650-nm Ga-Al-As
laser) stimulation reduces expression of TNF-α, a potent
pro-inflammatory cytokine, after acute immunocomplex
lung injury [153].
Increased release of some small molecules induced by LPLI
In addition to the molecules mentioned above, LPLI also
increases the production of some small molecules (Table
1). LPLI could induce the production of ATP, which leads
to normalization of cell function, pain relief, and wound
healing. The sufficient cellular energy enables cells to
work normally and is essential for successful self-healing
process [55,154-159]. LPLI could induce the production
of cyclic guanosine monophosphate (cGMP) in human
corpus cavernosum smooth muscle cells (HCC SMC)
[160]. LPLI also could induce the production of ROS
[9,12,22,24,34-37] and elevation of intracellular Ca2+
concentration [24-30]. The generation of small amounts
of ROS, as natural signal messengers, has been considered
to be important for regulating cell activities [22,35-37].
Each transient Ca2+ signal is characterized by an ampli-
tude and a duration, which are specific in their signaling
events [161]. This signal can be interpreted by the cells.
For example, the elevation of intracellular Ca2+ concentra-
tion or the complex frequency of Ca2+ oscillations are cor-
related with the spatio-temporal activation of Ras protein
through the ERK/MAPK cascade [162]. In addition, LPLI
can induce the production of NO in human umbilical
vein endothelial cell (HUVEC) [93], which promotes the
cell migration and angiogenesis [85,86,163,164].
The reasons why LPLI has different biologic effects on 
different cells
It appears that LPLI has different biologic effects on differ-
ent cells, and the followings are our comments on this
issue. First, we analyze these differences from the capabil-
ities of cell responding to LPLI. One key secondary reac-
tion invoked by LPLI is electronic excitation of the
mitochondrial respiratory chain components [45], which
leads to the production of ATP and various metabolic
processes, such as the synthesis of DNA, RNA, proteins,
Table 1: Modulation of expression and secretion of molecules by LPLI
Classification Molecules Biological effects of LPLI
Growth factors BDNF, GDNF, bFGF, IGF-I,
KGF, PDGF, TGF-β, VEGF
Proliferation, Differentiation,
Bone nodule formation
Interleukins IL-1α, IL-6, IL-8, IL-2, IL-4 Proliferation, Migration, Immunological activation
Inflammatory cytokines PGE2, COX-2, IL-1β, TNF-α Inhibition of inflammation
Small molecules ATP, cGMP, ROS, Ca2+, NO Normalization of cell function,
Pain relief, Healing, Mediating cell activities, Migration, AngiogenesisJournal of Biomedical Science 2009, 16:4 http://www.jbiomedsci.com/content/16/1/4
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enzymes, and other products needed to repair or regener-
ate cell components [12]. The specificity of final photo-
biological response is determined not at the level of
primary reactions in the respiratory chain but based on
secondary cellular signaling cascades [44]. In pathological
cells, these secondary cellular responses are inhibited
[165]. Thus, LPLI will have much more pronounced
effects due to the reduced cellular responses [166]. If the
cellular environment is optimal or near optimal (non-
pathological), the effects of LPLI will not be as pro-
nounced [166]. In essence, LPLI acts to normalize cellular
function, which is important to understand some of the
varying results of LPLI experimentation in the literatures
[166]. Secondly, we analyze the different biological effects
of LPLI from the redox status of the cells. It has been
shown that the biological effects of LPLI are dependent on
the initial redox status of the irradiated cells. The mito-
chondrial retrograde signaling pathways have been sug-
gested to be influenced by intracellular redox balance
[23]. In many cases, the regulative role of redox balance
has proved to be more important than that of ATP [23].
The cells whose overall redox potential is shifted to a more
reduced state (e.g., certain pathological conditions) are
more sensitive to irradiation. In contrast, cellular response
is weak or absent when the redox potential of the irradi-
ated cell is optimal or near optimal. This explains why
LPLI has different biologic effects on different cells and
why the biologic effects are sometimes nonexistent [44].
The above two explanations are analyzed from the differ-
ent initiate status of the irradiated cells, but the light-
induced biological effects also depend on the parameters
of the irradiation (wavelength, dose, intensity, radiation
time, continuous-wave or pulsed mode, pulse parame-
ters) [9,32,44,51,55]. For example, Karu [23] mentioned
that red light at 650 mn increased oxidative phosphoryla-
tion, but far-red light at 725 nm inhibited it when irradi-
ating isolated rat liver mitochondria, and that irradiation
at 670 and 830 nm stimulated the proliferation of the
Schwann cells, but irradiation at 780 nm inhibited it. It is
probably that the wavelengths mentioned above are
absorbed by different chromophores in a different redox
state and that different absorbing chromophores may play
a different role in driving the metabolism [23]. Another
example, our recent cellular viability assay revealed that
laser irradiation of low doses (≤ 25 J/cm2) promoted
HeLa cells viability while high doses impaired [22]. This
indicates that some beneficial effects may be lost if LPLI
doses are too high.
Due to the individual irradiated cell or individual param-
eter of the irradiation in different literatures, different cells
exhibit different biologic effects. According to the cDNA
microarray technique, the different biologic effects after
LPLI can be grouped into several categories. The gene
expression profiles of human fibroblasts reveals that 111
genes of 10 function categories are upregulated by the
low-intensity red light irradiation [167]. Among these 10
function categories, seven are directly or indirectly
involved in the enhancement of cell proliferation. The
other three function categories upregulated are genes
related to transcription factors, immune/inflammation
and cytokines as well as some genes not identified
[42,167]. Thus, these biological effects upon LPLI includ-
ing promotion of proliferation, regulation of immune/
inflammation, expression of transcription factors and
cytokines agree with our above reviewed photobiological
effects. Please note that the cells derived from different
classifications will be characterized as the specific
responses upon LPLI. For example, endothelial cells
involved in many aspects of vascular biology (such as
vasoconstriction, vasodilation and angiogenesis) exhibit
increased proliferation and migration after LPLI [93]. The
proliferation and migration of endothelial cell play criti-
cal roles in angiogenesis [89]. Mesenchymal stem cells
(MSCs) and cardiac stem cells (CSCs) [13], significant for
implantation in regenerative medicine, show increased
proliferation. Cell proliferation is a common response to
LPLI. The cells coming from hematological system show
their own features upon LPLI, such as erythrocytes with
the improved deformability after laser irradiation [168].
In inflamed mice lung neutrophils induced by lipopoly-
saccharide (LPS), LPLI stimulation reduces the inflamma-
tory response [141]. Helium-neon laser radiation (632.8
nm) on the thymus projection area of mice causes more
effective immunomodulatory effects in T cells [142].
Perspectives
Clinical applications for low power laser therapy (LPLT)
include wound healing, pain attenuation and various
forms of inflammation [33,169]. At present, there are a
large number of clinical trials using low power laser ther-
apy, but there are a relative small number of basic
researches of LPLI. Currently, the wavelengths, dosage
schedules, and appropriate conditions of laser irradiation
are not well established. Thus, to facilitate the physician to
match optimally the laser in clinical practices, the burning
issue is to study the basic mechanisms of the biological
effects of LPLI. Recently, the researchers pay close atten-
tion to the signaling pathways involved in the biological
effects of LPLI. It is believed now that extracellular stimuli
trigger cellular responses such as proliferation, differenti-
ation, and even apoptosis through the pathways of cellu-
lar signaling. Thus, we suppose that the investigation of
the molecular events induced by LPLI could eventually
reveal the mechanisms of LPLI. It is obvious that there are
close connections between mitochondrial retrograde sign-
aling and cellular molecular events such as the activation
or suppression of kinases in the cytoplasm and subse-
quent changes of downstream cascades. The elements ofJournal of Biomedical Science 2009, 16:4 http://www.jbiomedsci.com/content/16/1/4
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mitochondrial retrograde signaling (ΔΨm, ROS, Ca2+,
NO￿, pHi, fission-fusion homeostasis of mitochondria)
can mediate the cellular molecular events, but at present
we study less about it. Further studies investigating the
connections between mitochondrial retrograde signaling
and cellular molecular events are needed for understand-
ing the basic mechanisms of LPLI.
In this review, we summarized the studies on the molecu-
lar mechanisms of LPLI-induced proliferation since Janu-
ary 1999. Among these studies, one of the most
prominent features is that advanced techniques exten-
sively used in the study of cell biology are less used in the
basic research of LPLI. Most results of the basic researches
are obtained from traditional techniques in cell biology.
Thus, to better reveal the molecular mechanisms of LPLI,
we need combine the traditional techniques with the
innovative techniques. The basic researches of LPLI will
eventually guide the application of LPLI in clinical prac-
tices.
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